Dysmenorrhea Overview and Pipeline Review, H1 2015

Dysmenorrhea - Pipeline Review, H1 2015 Report is now available at RnRMarketResearch store. This report provides an overview of the Dysmenorrhea's therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Dysmenorrhea, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Dysmenorrhea and special features on late-stage and discontinued projects.

Get a copy of this report at . (This is a premium report price at US$2000 for a single user PDF license)


·         The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities

·         A review of the Dysmenorrhea products under development by companies and universities/research institutes based on information derived from company and industry-specific sources

·         Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages

·         A detailed assessment of monotherapy and combination therapy pipeline projects

·         Coverage of the Dysmenorrhea pipeline on the basis of target, MoA, route of administration and molecule type

·         Latest news and deals relating related to pipeline products

Table of Contents:

Introduction 5
Global Markets Direct Report Coverage 5
Dysmenorrhea Overview 6
Therapeutics Development 7
Pipeline Products for Dysmenorrhea - Overview 7
Pipeline Products for Dysmenorrhea - Comparative Analysis 8
Dysmenorrhea - Therapeutics under Development by Companies 9
Dysmenorrhea - Pipeline Products Glance 10
Clinical Stage Products 10
Early Stage Products 11
Dysmenorrhea - Products under Development by Companies 12
Dysmenorrhea - Companies Involved in Therapeutics Development 13